Zheng Quan Zhi Xing·2025-08-15 16:35Core Viewpoint - Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. has announced a mid-term profit distribution plan, proposing a cash dividend of RMB 0.40 per share (including tax) based on the total number of shares issued as of the record date for the distribution [1][2]. Group 1: Profit Distribution Plan - As of June 30, 2025, the company's undistributed profits amounted to RMB 7,568,559,146.29 [1]. - The total share capital of the company is 1,625,790,949 shares, leading to a total proposed cash dividend distribution of RMB 650,316,379.60 (including tax) [1]. - If there are changes in the total number of shares issued before the record date, the total distribution amount will remain unchanged, but the per-share distribution ratio will be adjusted accordingly [1]. Group 2: Decision-Making Process - The company's 2024 annual general meeting held on June 3, 2025, approved the profit distribution plan and authorized the board to implement the mid-term dividend distribution plan for 2025, provided it does not affect the company's normal operations and sustainable development [2]. - The ninth board meeting and the fourteenth supervisory board meeting held on August 15, 2025, reviewed and approved the mid-term profit distribution plan, confirming its compliance with the company's profit distribution policy and previously disclosed shareholder return plan [2].